Jianzhen completed the acquisition of Bayer Diabetes Care business through PHC in 2016, and handed over the business in China to Jianzhen China on June 1, 2016-Shanghai Jianzhen Medical Technology Co., Ltd. Jianzhen (Ascensia Diabetes Care Shanghai Co. Ltd.). Jianzhen China will continue to provide Bayer's previous sales and promotion of diabetes health care business products and related services. The product portfolio includes the world-famous CONTOUR blood sugar monitoring system series such as Baiankang and Baianjin.

Ascensia Diabetes Care is a professional global diabetes management company committed to improving the health of diabetics to improve their quality of life. Jianzhen has more than 80 years of innovative diabetes management products and strong innovative R&D channels. Its global headquarters is located in Basel, Switzerland, and its blood sugar monitoring products are sold in 125 countries.

Jianzhen China’s mission is to help diabetics through innovative solutions to simplify and improve their lives. In the future, Jianzhen will continue to be committed to the continuous research, innovation and development of new products to meet the daily challenges faced by diabetic patients.